What You Should Know:
Walgreens Boots Alliance announces the sale of shares of AmerisourceBergen Corporation valued at $1.85B for debt paydown and general corporate purposes.Walgreens Boots Alliance’s ownership stake of AmerisourceBergen’s common stock has not been impacted but is expected to decrease by to approximately 16 percent.
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Safety Intelligence is Redefining How Pharmacovigilance Teams Operate
The future of safety intelligence is now. New safety reporting and analytics advancements have redefined how pharmacovigilance (PV) teams operate by putting next-generation safety intelligence at the fingertips of those needing it most.
Teams that can streamline data flow and enable stakeholders to self-service real-time insights are delivering unprecedented value by enabling greater case management visibility and more informed, proactive decision-making.
Despite this, many PV
Read More
Health Equity Gets Boost from Biosimilars and Evidence-Based Treatment
Eliminating healthcare inequities requires addressing the underlying social and economic factors that contribute to these disparities and ensuring that all individuals have equal access to high-quality healthcare services, regardless of their background or circumstances. This includes addressing issues such as poverty, discrimination, and unequal distribution of resources, as well as promoting health equity as a core value of healthcare systems.
In recent years, there’s been a shift in the
Read More
Steve Jobs’ Son Launches $200M Fund to Fight Against Cancer
What You Should Know:
Reed Jobs - the son of Steve Jobs today announced the launch of his new venture capital (VC) investment fund, Yosemite, spun out from Emerson Collective Health with an oversubscribed $200M+ first close.Yosemite aims to meaningfully accelerate the technology, treatments, and standard of care that have the power to improve the health and lives of cancer patients.Composed of the Emerson Health team, Yosemite’s unique model provides no-strings-attached
Read More
Where Has All The Talent Gone? The Skills Gap Stalling The March of UK Life Sciences
The UK life sciences industry is burgeoning and, thanks in part to the role played by Covid in supercharging a range of sectors, it is on a path toward further expansion. Rishi Sunak, the Prime Minister, recently stated his ambition for the country to become a life sciences ‘superpower’.
However, at a time of unprecedented development, the industry also finds itself at the center of a skills shortage that threatens to stall, or even halt, its trajectory.
This skills gap is not only a
Read More
S&T Researchers Developing 3D-Printed Dressings for Better Wound Care
What You Should Know:
- Missouri University of Science and Technology researchers are developing new 3D-printed hydrogel dressings to speed up and improve the healing process for patients with second-degree burns. The research team published an article covering their latest findings in the International Journal of Bioprinting in July.
- Hydrogels are typically part of the care regimen for patients with severe burns, but what separates S&T’s research from standard hydrogels is that the
Read More
M&A: New Day Diagnostics to Acquire the Assets of Epigenomics AG
What You Should Know:
New Day Diagnostics LLC announced it has entered into an agreement to acquire the assets of Epigenomics AG, a molecular diagnostics company focused on blood testing for the early detection of cancer.Under the terms of the agreement, New Day Diagnostics would acquire substantially all of Epigenomics AG’s assets and intellectual property. The acquisition would expand New Day Diagnostics' portfolio in the cancer diagnostics space and include proprietary biomarker
Read More
NABP, IBM Partner to Build Platform to Protect Drug Supply Chain
What You Should Know:
The National Association of Boards of Pharmacy® (NABP®) and IBM Consulting are pleased to announce their collaboration to build Pulse by NABP™, a new digital platform that is intended to bring visibility to the drug supply chain and help protect patients from counterfeit or substandard prescription medications.Launching later in the summer of 2023, the platform is designed to facilitate manufacturers, wholesalers, pharmacies, and regulators to identify
Read More
ALZpath Secures Funding for Blood-Based Biomarker Testing for Alzheimer’s Disease Detection
What You Should Know:
- ALZpath, a developer of blood-based diagnostic biomarker testing for Alzheimer's disease detection receives funding from the Alzheimer’s Drug Discovery Foundation (ADDF)’s Diagnostics Accelerator to accelerate the clinical availability of ALZpathDx as a laboratory developed test (LDT).
- ALZpathDx is a novel, proprietary assay for blood-based measurement of phosphorylated tau at threonine 217 (pTau217), a highly accurate, diagnostic biomarker for
Read More
SiPhox Health Secures $27M for Lab-Grade Home Health Testing with Silicon Photonics
What You Should Know:
- Today, SiPhox Health, a Burlington, MA-based company building the next generation of lab-grade home health testing with silicon photonics raises $27M in funding, including a $10M Seed led by Khosla Ventures and Y Combinator, and a $17M Series A led by Intel Capital.
- The SiPhox Home and Health testing systems offer innovative and efficient blood collection solutions for consumers, healthcare systems, pharmaceutical companies, and research teams focusing on
Read More
